Enhancement of blood-brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice.
Enhancement of blood-brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice.
复制标题
DOI:
10.1016/j.antiviral.2014.07.013
复制
发表时间:
2014-10
影响因子:
7.6
通讯作者:
Fu, Zhen F.
中科院分区:
文献类型:
--
作者:
Huang, Chien-Tsun;Li, Zhenguang;Huang, Ying;Zhang, Guoqing;Zhou, Ming;Chai, Qingqing;Wu, Hua;Fu, Zhen F.
Intravenous administration of VNAs can protect mice from developing rabies when the BBB permeability is enhanced. MCP-1 enhances BBB permeability by down-regulation of TJ proteins in the brain microvasculature. Enhancement of the BBB permeability correlates with the increase of VNA in and the clearance of RABV from the CNS. Rabies virus (RABV) is a neurotropic virus that causes fatal disease in humans and animals. Currently there is no cure for rabies once clinical signs appear. It is believed that once RABV enters the central nervous system (CNS), virus neutralizing antibodies (VNAs) in the periphery cannot pass through the blood–brain barrier (BBB) and into the CNS. Furthermore, it has been hypothesized that VNAs produced in the CNS by invading B cells, rather than those produced in the periphery and then transported into the CNS, are important in clearing RABV from the CNS. In the present study, mouse serum containing VNA was administered intravenously into mice after infection with wild-type RABV. Our studies demonstrate that exogenous administration of VNAs is crucial in the clearance of RABV from the brain and prevent the development of rabies in both immunocompetent and immunocompromised mice as long as the BBB permeability remains enhanced. This present study therefore provides a foundation for the possibility of developing VNA therapy for clinical rabies in humans.
登录
查看更多内容
影响因子:
64.8
作者:
Kim, Jiyun V.;Kang, Silvia S.;Dustin, Michael L.;McGavern, Dorian B.
通讯作者:
McGavern, Dorian B.
影响因子:
5
作者:
Kuang, Yi;Lackay, Sarah N.;Zhao, Ling;Fu, Zhen F.
通讯作者:
Fu, Zhen F.
影响因子:
5.4
作者:
Chai, Qingqing;He, Wen Q.;Fu, Zhen F.
通讯作者:
Fu, Zhen F.
影响因子:
9.8
作者:
Hampson K;Dushoff J;Cleaveland S;Haydon DT;Kaare M;Packer C;Dobson A
通讯作者:
Dobson A
影响因子:
3.8
作者:
Hooper DC;Phares TW;Fabis MJ;Roy A
通讯作者:
Roy A